Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 225, pseudogene (RNU6-225P) is classified as a **pseudogene** related to the U6 small nuclear RNA (snRNA) family[1]. The U6 snRNA is an essential non-coding RNA component of the spliceosome, involved in pre-mRNA splicing in eukaryotic cells[2][3]. However, *RNU6-225P* itself does not produce a functional snRNA transcript and is not known to have any biological activity or role in disease, drug targeting, or biomarker application. Pseudogenes like RNU6-225P represent non-functional genomic sequences similar to functional RNA genes but are generally considered transcriptionally inactive[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 225, pseudogene (RNU6-225P).